-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$40.86252.85% Upside
Evolent Health, Inc. Frequently Asked Questions
-
What analysts cover Evolent Health, Inc.?
Evolent Health, Inc. has been rated by research analysts at Oppenheimer, Stephens, Truist Financial, RBC Capital, Piper Sandler, Canaccord Genuity in the past 90 days.